United States Digital Pathology Market

United States Digital Pathology Market Size and Share:

The United States digital pathology market size was valued at USD 347.48 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 853.47 Million by 2033, exhibiting a CAGR of 9.70% from 2025-2033. The market is experiencing growth because of the increasing demand for accurate and efficient diagnostic solutions, rising adoption of telepathology for remote consultations, and advancements in artificial intelligence (AI)-driven image analysis. Additionally, improved workflow efficiency, technological innovations in slide scanners, and supportive government initiatives promoting digital healthcare infrastructure are contributing to the market growth in the United States.

At present, the increasing cases of cancer and other chronic conditions, which require precise diagnostics and pathology services, represents one of the major factors impelling the market growth in the United States. Digital pathology supports better collaboration and sharing of slides among specialists, aiding in faster and more accurate diagnoses. The rising patient load is encouraging hospitals and laboratories to adopt these systems and address capacity challenges. Furthermore, innovations in whole-slide imaging (WSI), high-resolution scanners, and artificial intelligence (AI)-powered tools are enhancing diagnostic capabilities. AI algorithms streamline pathology workflows by automating tasks such as image analysis, enabling faster and more accurate detection of diseases like cancer. These tools are improving efficiency, reducing diagnostic turnaround times, and supporting pathologists in decision-making.

In addition, the growing need for remote diagnostics is accelerating the adoption of telepathology, allowing pathologists to analyze slides from different locations. Enhanced internet connectivity and secure cloud-based platforms make it easier to share digital slides for consultation and second opinions. Besides this, pharmaceutical companies are using digital pathology to accelerate clinical trials and drug discovery. These systems facilitate efficient biomarker analysis, image storage, and collaboration between researchers, reducing study timelines. The integration of AI tools further enhances image interpretation for faster results. Additionally, the shift in healthcare toward value-based care models is motivating providers to improve diagnostic accuracy and efficiency. Digital pathology helps achieve this goal by reducing manual errors, enabling data-driven insights, and supporting personalized treatment planning. As healthcare systems aim for better patient outcomes, digital tools are becoming essential in pathology workflows.

United States Digital Pathology Market Trends:

Rising Demand for Faster and Accurate Diagnostics

Healthcare providers face a growing patient volumes and complex disease cases, particularly cancer, which requires detailed and efficient pathology analysis. Digital pathology accelerates workflows by converting traditional glass slides into high-resolution digital images, enabling quicker analysis and reducing turnaround times. AI-powered tools further enhance accuracy by automating image analysis, detecting patterns, and prioritizing critical cases. This technology minimizes human error, supports better diagnostic outcomes, and improves patient care. Hospitals and laboratories increasingly rely on digital solutions to optimize processes and meet demands for precision diagnostics, particularly in pathology-heavy departments. In 2024, Proscia received FDA 510(k) clearance for its Concentriq AP-Dx digital pathology software, enabling primary diagnosis using whole slide images in the United States. The solution enhances pathologist efficiency, collaboration, and diagnostic confidence, addressing increasing demands in cancer care. This milestone marks significant progress in advancing precision medicine and digital pathology adoption.

Expansion of Research and Drug Development Activities

The rise of research and drug development initiatives is driving the adoption of digital pathology in the United States. Pharmaceutical companies, biotechnology firms, and academic research institutions rely on digital pathology for preclinical studies, clinical trials, and biomarker discovery. High-resolution digital imaging and AI-based tools enhance the analysis of tissue samples, accelerating research timelines and improving accuracy in identifying disease patterns. These solutions allow researchers to efficiently analyze large datasets, collaborate remotely, and ensure reproducible results. Digital pathology also enables virtual access to slides, enhancing collaborative studies and international partnerships. In 2024, Microsoft, the University of Washington, and Providence launched Prov-GigaPath, an AI model trained on 1.3 billion pathology images from 171,000 slides. This large-scale model improves cancer diagnostics by analyzing entire slides to predict gene mutations, tumor subtypes, and therapy responses.

Increasing Prevalence of Cancer and Chronic Diseases

The rising incidence of cancer and other chronic diseases is a key factor supporting the market growth. Pathology is essential in diagnosing, tracking, and managing these illnesses, leading to a need for advanced tools that improve both efficiency and precision. Digital pathology allows pathologists to examine intricate tissue samples more efficiently, guaranteeing prompt detection and diagnosis. Advanced imaging techniques and AI-powered analytical tools offer more profound insights into cancer development and treatment efficacy. Clinics and testing facilities are embracing digital tools to manage the increasing case loads while ensuring accuracy and reliability. With the healthcare system experiencing mounting pressure to tackle the growing disease burden, digital pathology aids in optimizing workflows, minimizing diagnostic delays, and enhancing patient outcomes by offering dependable, scalable diagnostic assistance. For instance, in 2024, Alverno Laboratories partnered with Ibex Medical Analytics to integrate AI-based pathology solutions across its Midwest network. The system enhances cancer diagnosis for prostate, breast, and stomach biopsies, boosting accuracy and shortening turnaround times. The combination of digital pathology and AI upgrades patient care and boosts pathologist productivity in the United States.

United States digital pathology Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the United States digital pathology market, along with forecasts at the regional and country levels from 2025-2033. The market has been categorized based on product, type, delivery model, application, and end user.

Analysis by Product:

• Scanners
• Software
• Storage Systems
• Communication Systems
   

Scanners play an essential role in the digital pathology sector, facilitating the transformation of conventional glass slides into high-resolution digital images. The need for sophisticated slide scanners is rising because of their effectiveness in obtaining sharp, detailed images for diagnostics and research. Advancements like quicker scanning rates, increased throughput, and improved image resolution are propelling adoption in laboratories and healthcare settings.

Software is essential in digital pathology, offering tools for managing, analyzing, and sharing images. AI-powered solutions are revolutionizing the sector by automating image assessments and enhancing diagnostic precision. Capabilities such as workflow enhancement, remote teamwork, and compatibility with laboratory information systems (LIS) are boosting operational efficiency, positioning software as a vital component in contemporary pathology practices.

Storage systems are crucial for handling the vast amounts of high-resolution images produced in digital pathology. As digitization expands, there is a growing need for secure and scalable storage solutions. Cloud-based solutions are becoming more popular because of their accessibility and affordability, whereas on-site systems continue to be essential for organizations that need high levels of data security and adherence to regulations.

Communication systems enable effortless data exchange and cooperation among pathologists, researchers, and healthcare professionals. Telepathology, facilitated by cutting-edge communication technologies, aids in remote diagnostics and consultations, overcoming geographical obstacles. The combination of communication tools and digital platforms provides immediate access to essential pathology data, improving collaboration, decision-making, and patient results.

Analysis by Type:

• Human Pathology
• Veterinary Pathology
   

Human pathology holds a considerable portion of the market, supported by the rising incidence of chronic illnesses like cancer and the demand for accurate diagnostics. Digital tools improve workflow efficiency, allowing pathologists to examine intricate cases more quickly and with increased precision. Utilization of AI-driven tools for image analysis, along with telepathology, enhances remote consultations and cooperation between healthcare professionals, leading to better patient care results.

Veterinary pathology is experiencing consistent expansion as digital pathology technologies are implemented in animal diagnostics and research. Veterinary clinics and diagnostic facilities are utilizing advanced technologies to enhance efficiency in examining tissue samples and detecting illnesses in animals. Digital pathology speeds up results, enhances collaboration among specialists, and improves disease management in companion animals, livestock, and veterinary research initiatives.

Analysis by Delivery Model:

• On-premises
• Hosted
   

The on-premises delivery model is preferred by organizations requiring complete control over data security and infrastructure. Institutions handling sensitive patient information favor this model to comply with strict regulatory standards. On-premises solutions offer reliable performance, reduced latency, and tailored configurations, making them ideal for high-volume laboratories and large healthcare facilities that prioritize privacy and consistent system availability.

The hosted delivery model, including cloud-based solutions, is gaining traction due to its flexibility, scalability, and cost-effectiveness. These solutions allow pathologists to access data remotely, enabling seamless collaboration and faster diagnostics. Hosted platforms reduce infrastructure costs and maintenance efforts while ensuring secure data storage and real-time updates, making them ideal for smaller laboratories, research institutions, and organizations with remote pathology needs.

Analysis by Application:

• Training and Education
• Consulting Services
• Intraoperative Consultation
• Routine Diagnostic Consultation Services
• Others
   

Digital pathology is transforming training and education by providing interactive, high-resolution slides that can be accessed. Medical institutions use these tools to educate students and professionals in pathology, enabling hands-on learning without physical slides. The ability to share cases digitally enhances collaboration and helps trainees develop diagnostic expertise through real-world examples and AI-assisted learning modules.

Consulting services in digital pathology facilitate expert collaboration for complex cases. Pathologists can share digital slides with specialists for second opinions and detailed analyses, ensuring accurate diagnoses. These services are particularly valuable for rare disease cases, enabling faster, expert-driven results. The adoption of teleconsulting solutions further bridges gaps in expertise, enhancing decision-making and patient care outcomes.

Intraoperative consultation gains advantages from digital pathology as it allows for quick examination of tissue samples during operations. Digital technologies enable pathologists to offer immediate insights to surgical teams, guaranteeing accurate interventions. The efficiency and precision provided by digital solutions enhance decision-making, decrease operational time, and lead to improved surgical results, especially in cancer-related surgeries.

Routine diagnostic consultation services are the largest application area, as digital pathology enhances efficiency and accuracy in everyday diagnostics. High-resolution image analysis tools streamline workflows, reducing turnaround times for pathology results. The integration of AI-based systems further aids in identifying abnormalities, allowing pathologists to focus on critical cases and improving overall diagnostic throughput.

Others include research applications, clinical studies, and medication discovery. Digital pathology facilitates extensive research by allowing effective data evaluation, image distribution, and storage. Researchers gain from enhanced access to digitized slides, promoting collaboration and speeding up discoveries in disease pathology, drug effectiveness, and biomarker identification.

Analysis by End User:

• Pharmaceutical and Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic and Research Institutes
   

Pharmaceutical and biotechnology companies are adopting digital pathology for drug discovery, preclinical and clinical trials, and biomarker research. High-resolution imaging and AI-driven analysis accelerate the identification of disease markers and drug responses. Digital pathology improves efficiency in analyzing large datasets, enabling faster decision-making, reducing costs, and supporting the development of innovative therapeutics.

Hospitals and reference laboratories utilize digital pathology to enhance diagnostic accuracy, streamline workflows, and manage high case volumes efficiently. Integration of telepathology enables remote consultations, facilitating expert input on complex cases. The adoption of AI-powered tools aids pathologists in identifying abnormalities and prioritizing critical cases, improving patient outcomes and reducing turnaround times for pathology reports.

Academic and research institutes depend on digital pathology for teaching, investigation, and cooperative studies. Digital resources provide access to extensive digitized slide collections for education, allowing students to study real-world examples. In research, digital pathology improves data analysis, facilitates image sharing, and fosters collaboration among scientists, aiding advancements in disease comprehension, biomarker identification, and medication development.

Regional Analysis:

• Northeast
• Midwest
• South
• West
   

Northeast is a key adopter of digital pathology, driven by its concentration of advanced healthcare systems, research institutions, and biotechnology companies. The presence of renowned academic centers and hospitals fosters innovation in diagnostics and pathology practices. High investment in research operations supports the deployment of advanced tools, enhancing diagnostic accuracy and improving patient care outcomes.

In the Midwest, the uptake of digital pathology is rising because of the region's commitment to enhancing healthcare infrastructure and broadening laboratory capabilities. Numerous hospitals and reference laboratories are incorporating digital solutions to enhance workflows and facilitate telepathology. The area's engaged involvement in clinical studies and partnerships with biotech companies additionally enhances market expansion.

South is experiencing notable growth in digital pathology, driven by the rising demand for improved diagnostics and increased adoption of telepathology services. The presence of large healthcare facilities and growing research initiatives fuels the deployment of advanced solutions. Investments in AI-based tools and workflow automation are improving efficiency, supporting both clinical diagnostics and educational purposes.

West is adopting digital pathology, supported by its strong presence of technology hubs and cutting-edge healthcare facilities. High demand for innovative diagnostic tools and AI-driven solutions accelerates growth in this region. The West also plays a vital role in advancing research initiatives, with academic institutions and biotech companies leveraging digital pathology to drive breakthroughs in diagnostics and drug development.

Competitive Landscape:

Major participants in the market are concentrating on creating sophisticated imaging technologies, AI-powered diagnostic solutions, and cloud-based systems to improve precision and effectiveness. They are putting funds into research and development to incorporate artificial intelligence for automated image assessment and enhanced workflows. Businesses are broadening their market access via strategic alliances, acquisitions, and collaborations with healthcare providers, research facilities, and laboratories. The pursuit of achieving regulatory requirements and delivering secure, scalable solutions is growing, especially as cloud-based systems facilitate remote diagnostics. Many players are also enhancing telepathology capabilities to offer consultations and second opinions. Additionally, manufacturers are improving scanner technologies and software solutions to streamline processes, support large-scale data handling, and enable seamless integration with existing healthcare infrastructure. In 2024, Sectra and Leica Biosystems became the first to receive FDA clearance for using DICOM images in pathology diagnostics. This milestone supports standardization in digital pathology, improving efficiency, interoperability, and patient care. The solution enhances workflows by enabling seamless access and review of tissue images.

The report provides a comprehensive analysis of the competitive landscape in the United States digital pathology market with detailed profiles of all major companies.

Latest News and Developments:

• June 2024: NYU Langone Health launched its digital pathology program, transitioning from microscopes to high-definition, shareable images for faster and more efficient disease diagnoses. The program improves collaboration, reduces delays, and integrates AI for enhanced diagnostics. This initiative addresses the pathologist shortage while elevating patient care standards.
• June 2024: Sectra launched a new genomics IT module for molecular pathology in collaboration with the University of Pennsylvania Health System in the USA. This solution enables cancer diagnostics based on genomic data, advancing personalized medicine and tailored treatment plans. Fully integrated with medical records, it reduces IT burdens and enhances precision care.

United States Digital Pathology Market Report Scope:

Key Benefits for Stakeholders:

• IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States digital pathology market from 2019-2033.
• The research study provides the latest information on the market drivers, challenges, and opportunities in the United States digital pathology market.
• Porter's Five Forces analysis assists stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the United States digital pathology industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.